FDA awards humanitarian status to Exalenz's liver diagnostic tool

09/11/2011 | Globes (Israel)

Exalenz Bioscience has secured humanitarian device exemption status from the FDA for its BreathID device in the diagnosis of acute liver failure, shortening its process to FDA approval. The designation comes a week after the company received FDA approval for a clinical study designed to evaluate the efficacy of the device in detecting liver cancer at an early stage.

View Full Article in:

Globes (Israel)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Counsel, Regulatory (FDA)
CareFusion
San Diego , CA
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations